Free Trial

Baldwin Wealth Partners LLC MA Sells 1,841 Shares of Procter & Gamble Company (The) $PG

Procter & Gamble logo with Consumer Staples background

Key Points

  • Baldwin Wealth Partners LLC MA reduced its stake in Procter & Gamble by 3.5%, selling 1,841 shares and retaining 50,428 shares worth approximately $8.03 million as of the end of the second quarter.
  • Institutional investors currently hold 65.77% of Procter & Gamble's stock, with significant increases in ownership from firms like Kingstone Capital Partners, which raised its stake by 655,209%.
  • Recent analyst reports have led to mixed ratings for Procter & Gamble, with a consensus target price of $172.58 and a split recommendation of eleven "Buy" ratings versus nine "Hold" ratings.
  • Interested in Procter & Gamble? Here are five stocks we like better.

Baldwin Wealth Partners LLC MA cut its position in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 3.5% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 50,428 shares of the company's stock after selling 1,841 shares during the quarter. Baldwin Wealth Partners LLC MA's holdings in Procter & Gamble were worth $8,034,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in PG. Kingstone Capital Partners Texas LLC raised its stake in shares of Procter & Gamble by 655,209.0% in the second quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company's stock valued at $11,832,680,000 after buying an additional 76,017,350 shares during the period. Nuveen LLC bought a new stake in shares of Procter & Gamble in the first quarter valued at $1,954,941,000. Price T Rowe Associates Inc. MD raised its stake in shares of Procter & Gamble by 13.0% in the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company's stock valued at $3,660,737,000 after buying an additional 2,466,308 shares during the period. Invesco Ltd. raised its stake in shares of Procter & Gamble by 19.8% in the first quarter. Invesco Ltd. now owns 13,493,604 shares of the company's stock valued at $2,299,580,000 after buying an additional 2,228,151 shares during the period. Finally, Valeo Financial Advisors LLC raised its stake in shares of Procter & Gamble by 1,875.5% in the second quarter. Valeo Financial Advisors LLC now owns 1,763,404 shares of the company's stock valued at $280,946,000 after buying an additional 1,674,139 shares during the period. 65.77% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

PG has been the topic of a number of recent research reports. Berenberg Bank increased their price objective on Procter & Gamble from $152.00 to $154.00 and gave the stock a "hold" rating in a report on Wednesday, September 17th. JPMorgan Chase & Co. reissued a "neutral" rating and set a $170.00 price objective (down previously from $178.00) on shares of Procter & Gamble in a report on Friday, July 25th. Barclays dropped their price objective on Procter & Gamble from $164.00 to $153.00 and set an "equal weight" rating on the stock in a report on Wednesday, October 1st. Weiss Ratings reissued a "hold (c+)" rating on shares of Procter & Gamble in a report on Wednesday. Finally, BNP Paribas reissued an "outperform" rating and set a $177.00 price objective on shares of Procter & Gamble in a report on Friday, August 15th. Eleven equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company's stock. Based on data from MarketBeat, Procter & Gamble presently has an average rating of "Moderate Buy" and a consensus target price of $172.58.

Check Out Our Latest Stock Report on PG

Insider Activity

In other news, insider Marc S. Pritchard sold 9,849 shares of the stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $1,548,952.23. Following the transaction, the insider directly owned 182,422 shares in the company, valued at approximately $28,689,507.94. This represents a 5.12% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Shailesh Jejurikar sold 13,039 shares of the stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total value of $2,050,643.53. Following the sale, the chief operating officer owned 28,036 shares of the company's stock, valued at $4,409,221.72. This represents a 31.74% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 149,763 shares of company stock worth $23,421,279. 0.20% of the stock is currently owned by insiders.

Procter & Gamble Price Performance

Shares of Procter & Gamble stock opened at $150.53 on Friday. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49. The firm has a market capitalization of $352.31 billion, a PE ratio of 23.12, a price-to-earnings-growth ratio of 4.00 and a beta of 0.36. The business's 50-day moving average price is $155.26 and its 200-day moving average price is $159.62. Procter & Gamble Company has a 12 month low of $149.58 and a 12 month high of $180.43.

Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, beating the consensus estimate of $1.42 by $0.06. The firm had revenue of $20.89 billion for the quarter, compared to analyst estimates of $20.79 billion. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The company's revenue was up 1.7% on a year-over-year basis. During the same period in the prior year, the company earned $1.40 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Sell-side analysts forecast that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.

Procter & Gamble Company Profile

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Further Reading

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Procter & Gamble Right Now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.